CVC Stock Analysis: CVC Capital | AS
Asset Management | AS, Netherlands | Market Cap: 13.787m EUR | 12M Return: -19.4% | JE00BRX98089 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 15.2M
Rev. Trend: 96.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.4 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
CVC Capital Partners plc is a private equity and venture capital firm offering services across middle-market secondaries, infrastructure, credit, management and leveraged buyouts, growth equity, and recapitalizations. As an asset manager, the firm typically generates revenue through management fees on assets under management and performance-based carried interest from successful investments. It targets medium to large-sized businesses across a broad range of sectors, including fintech, healthcare, industrials, IT, telecommunications, energy, chemicals, consumer goods, media, and real estate. Its Growth Partners strategy focuses on software and technology-enabled business services, while its European infrastructure strategy targets transport, utilities, government services, communications, and energy. CVC prefers to invest in companies based across Europe, North America, and Asia-Pacific, with particular emphasis on France, Italy, Germany, and Switzerland. For its Asia private equity strategy, the firm targets companies with enterprise values between USD 250 million and USD 1.5 billion, while its CVC Catalyst strategy focuses on equity investments starting at approximately €75 million ($86.36 million).
- Fee-related earnings expand on record AUM growth
- Carry realizations accelerate as portfolio IPOs and exits rebound
- Higher rates and deal competition pressure fundraising pace
| Net Income: 1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -5.36 > 1.0 |
| NWC/Revenue: 72.86% < 20% (prev 24.33%; Δ 48.53% < -1%) |
| CFO/TA 0.11 > 3% & CFO 624.6m > Net Income 1.33b |
| Net Debt (1.51b) to EBITDA (1.62b): 0.94 < 3 |
| Current Ratio: 9.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.09b) vs 12m ago -0.04% < -2% |
| Gross Margin: 85.21% > 18% (prev 77.42%; Δ 7.79% > 0.5%) |
| Asset Turnover: 45.17% > 50% (prev 45.39%; Δ -0.22% > 0%) |
| Interest Coverage Ratio: 25.08 > 6 (EBIT TTM 1.42b / Interest Expense TTM 56.6m) |
| A: 0.31 (Total Current Assets 1.96b - Total Current Liabilities 215.0m) / Total Assets 5.69b |
| B: 0.11 (Retained Earnings 635.0m / Total Assets 5.69b) |
| C: 0.27 (EBIT TTM 1.42b / Avg Total Assets 5.30b) |
| D: 0.46 (Book Value of Equity 1.58b / Total Liabilities 3.44b) |
| Altman-Z'' = 4.65 = AA |
| DSRI: 1.56 (Receivables 365.0m/217.8m, Revenue 2.40b/2.23b) |
| GMI: 0.91 (GM 77.42% / 85.21%) |
| AQI: 0.80 (AQ_t 0.62 / AQ_t-1 0.78) |
| SGI: 1.07 (Revenue 2.40b / 2.23b) |
| TATA: 0.12 (NI 1.33b - CFO 624.6m) / TA 5.69b) |
| Beneish M = -2.70 (Cap -4..+1) = A |
As of September 27, 2026, the stock is trading at EUR 12.37 with a total of 763,476 shares traded. Over the past week, the price has changed by -2.21%, over one month by -17.86%, over three months by -19.43% and over the past year by -19.43%.
Current recommended Stop Loss: 11.80 (which is 4.6% or 1.6 ATR below the current price).
CVC Capital has no consensus analysts rating.
P/E Trailing = 16.4286
P/E Forward = 13.7552
P/S = 6.8717
P/B = 9.0205
P/EG = 1.1099
Revenue TTM = 2.40b EUR
EBIT TTM = 1.42b EUR
EBITDA TTM = 1.62b EUR
Long Term Debt = 2.05b EUR (from longTermDebt, last quarter)
Short Term Debt = 215.0m EUR (from shortTermDebt, last quarter)
Debt = 2.55b EUR (from shortLongTermDebtTotal, last quarter) + Leases 158.0m
Net Debt = 1.51b EUR (calculated: Debt 2.55b - CCE 1.03b)
Enterprise Value = 15.3b EUR (13.8b + Debt 2.55b - CCE 1.03b)
Interest Coverage Ratio = 25.08 (Ebit TTM 1.42b / Interest Expense TTM 56.6m)
EV/FCF = 25.68x (Enterprise Value 15.3b / FCF TTM 595.9m)
FCF Yield = 3.89% (FCF TTM 595.9m / Enterprise Value 15.3b)
FCF Margin = 24.88% (FCF TTM 595.9m / Revenue TTM 2.40b)
Net Margin = 55.53% (Net Income TTM 1.33b / Revenue TTM 2.40b)
Gross Margin = 85.21% ((Revenue TTM 2.40b - Cost of Revenue TTM 354.3m) / Revenue TTM)
Gross Margin QoQ = 72.68% (prev 72.68%)
Tobins Q-Ratio = 2.69 (Enterprise Value 15.3b / Total Assets 5.69b)
Interest Expense / Debt = 2.22% (Interest Expense 56.6m / Debt 2.55b)
Taxrate = 4.56% (64.4m / 1.41b)
NOPAT = 1.35b (EBIT 1.42b * (1 - 4.56%))
Current Ratio = 9.12 (Total Current Assets 1.96b / Total Current Liabilities 215.0m)
Debt / Equity = 1.62 (Debt 2.55b / totalStockholderEquity, last quarter 1.58b)
Debt / EBITDA = 0.94 (Net Debt 1.51b / EBITDA 1.62b)
Debt / FCF = 2.54 (Net Debt 1.51b / FCF TTM 595.9m)
Total Stockholder Equity = 1.60b (last 4 quarters mean from totalStockholderEquity)
RoA = 25.09% (Net Income 1.33b / Total Assets 5.69b)
RoE = 83.23% (Net Income TTM 1.33b / Total Stockholder Equity 1.60b)
RoCE = 38.94% (EBIT 1.42b / Capital Employed (Equity 1.60b + L.T.Debt 2.05b))
RoIC = 24.31% (NOPAT 1.35b / Invested Capital 5.57b)
WACC = 7.90% (E(13.8b)/V(16.3b) * Re(8.97%) + D(2.55b)/V(16.3b) * Rd(2.22%) * (1-Tc(0.05)))
Discount Rate = 8.97% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 69.58 | Cagr: 13.01%
[DCF] Terminal Value 73.10% ; FCFF base≈668.9m ; Y1≈586.5m ; Y5≈473.9m
[DCF] Fair Price = 5.59 (EV 7.61b - Net Debt 1.51b = Equity 6.09b / Shares 1.09b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 96.83 | Revenue CAGR: 37.24% | SUE: N/A | # QB: 0
EPS current Year (2026-12-31): EPS=0.80 | Chg30d=-0.05% | Revisions=+17% | GrowthEPS=+1.4% | GrowthRev=+9.7%
EPS next Year (2027-12-31): EPS=0.92 | Chg30d=-0.93% | Revisions=-17% | GrowthEPS=+14.6% | GrowthRev=+14.1%
[Analyst] Revisions Ratio: +0% (up=3, down=3)